Justin Kern

Partner, DCVC Bioat Dcvc· CA
Current roles
2
Investments attributed
2
Board seats
1
Form D directors and board-seat deals
As of · this person's identity; each section below carries its own date

What matters now

  1. 1 deal
    12 months

    1 investment attributed in the last 12 months; latest AgZen Series B ($10M) on 13 Mar 2026.

    A partner with a recent deal is actively writing cheques now.

    Factfunding announcements and Form D naming the personFor Founders, co-investorsInvestments →
  2. Current
    role

    Partner, DCVC Bio at Dcvc.

    Tenure says how settled this partner is at the firm.

    FactForm ADV Schedule A and the firm's team pageFor Founders, LPsRoles →
Drawing the relationship network…

Roles

2 current, 0 past
  • Dcvc Partner, DCVC Bio
    ? to present · “team page: Dr. Justin Kern / Partner, DCVC Bio”
  • Dcvc Bio Partner
    ? to present · “said Justin Kern, Partner at DCVC Bio.”

Investments attributed to this person

2
CompanyRoundInvestorAttributionDateSource
AgZenSeries B · $10.0M · Series BDcvc BioconfirmedMar 13, 2026Fact globenewswire.com
AgZenForm D equity offering · $10.0MDcvcstrongly supported · boardFeb 7, 2025Inference sec.gov

Board seats and vehicles

1 board, 0 vehicles
  • AgZen board seat on a deal Feb 7, 2025 Inference

Timeline

2 dated entries: events, attributed deals, board seats and role changes
  1. Mar 13, 2026
    Series B in AgZen (Dcvc Bio)
    Attributed investment Fact AgZen Press release
  2. Feb 7, 2025
    Form D equity offering in AgZen (Dcvc)
    Attributed investment Inference AgZen Form D